Completed PHASE3 NCT00000529

Tamoxifen Study

Sponsor: NSABP Foundation Inc

Conditions Cardiovascular Diseases Coronary Disease Heart Diseases Hypertension Myocardial Ischemia

Interventions tamoxifen

Updated 5 times since 2017 Last updated: Nov 1, 2016 Started: May 31, 1992 Completion: Nov 30, 1995

A PHASE3 clinical study on Cardiovascular Diseases and Coronary Disease, this trial is completed. The trial is conducted by NSABP Foundation Inc and has accumulated 5 data snapshots since 1992. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

May 1992

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

NSABP Foundation Inc
National Cancer Institute (NCI)

Data source: National Heart, Lung, and Blood Institute (NHLBI)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.